Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Iovance Biotherapeutics, Inc.”

91 pharma patents match "Iovance Biotherapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 91
Index total 30,257
Page 3 / 4

Quick answer

This filtered view shows 91 pharmaceutical patents matching "Iovance Biotherapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

91 results for “Iovance Biotherapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 11273180

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted

  2. US 11273181

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted

  3. US 11266694

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted

  4. US 11254913

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  5. US 11241456

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted

  6. US 11220670

    Remnant tumor infiltrating lymphocytes and methods of preparing and using the same

    Iovance Biotherapeutics, Inc. · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  7. US 11202803

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted

  8. US 11202804

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted

  9. US 11179419

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

  10. US 11168304

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  11. US 11168303

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  12. US 11141434

    Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof

    Iovance Biotherapeutics, Inc. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted

  13. US 11141438

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted

  14. US 11123371

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  15. US 11083752

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted

  16. US 11058728

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  17. US 11052115

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  18. US 11052116

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  19. US 11040070

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted

  20. US 11026974

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  21. US 11013770

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 25, 2021 · Expires May 20, 2041

    granted

  22. US 11007226

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted

  23. US 10953046

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  24. US 10953047

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.